Cryptopolitan on MSN
JINX-0164 hijacks crypto developer machines through phony meeting links
A group of hackers, named JINX-0164, has been contacting crypto devs via LinkedIn and inviting them to fake meetings that ...
Weekly ThreatsDay recap: old bugs, fake tools, shady payload tricks, AI mishaps, and the usual reminder that the internet is ...
A threat actor tracked as DriveSurge has been operating large-scale malware distribution campaigns using ClickFix and ...
Researchers at the University of Toronto showed how hackers could use artificial intelligence to create a program that could ...
Fake Claude Code install sites are pushing malware that steals API keys, developer credentials, crypto wallets, and other ...
A website called “UK visa portal” has been quietly collecting passport scans, selfies, and personal data from thousands of travellers who thought they were applying through official channels.
Opinion
This Week In Security: Messing With AI, 7Zip And Notepad++ Vulnerabilities, HTTP2 Bomb, And More
With the rise of AI coding assistants continuing apparently unabated, some project maintainers have begun striking back. Ars Technica reports on projects putting hostile directions into the ...
A large-scale campaign impersonates open-source and freeware project portals to redirect users through a gated TDS and ...
Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...
Cybersecurity researchers at Aikido Security have uncovered a malicious supply chain attack targeting OpenAI Codex developers via the npm package “codexui-android”. While the associated GitHub ...
Morning Overview on MSN
Hackers just hid their phishing trap inside the Markdown links and images ChatGPT renders for you — turning the AI assistant itself into the attack channel
Ask ChatGPT to summarize a web page and you expect a tidy set of bullet points, maybe a helpful link or two. What you ...
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results